Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

✍ Scribed by John MS Bartlett; Alison F Munro; Janet A Dunn; Christopher McConkey; Sarah Jordan; Chris J Twelves; David A Cameron; Jeremy Thomas; Fiona M Campbell; Daniel W Rea; Elena Provenzano; Carlos Caldas; Paul Pharoah; Louise Hiller; Helena Earl; Christopher J Poole

• Book ID: 117785267
• Publisher: The Lancet
• Year: 2010
• Tongue: English
• Weight: 134 KB
• Volume: 11
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(10)70006-1